Risk of Macrophage Activation Syndrome in Patients with Adult-Onset Still's Disease Treated with IL-1 and IL-6 Inhibitors: A Meta-analysis and Single-Center Experience.
Soichiro AdachiKaoru Takase-MinegishiAyaka MaedaHideto NagaiNobuyuki HoritaRyusuke YoshimiYohei KirinoHideaki NakajimaPublished in: Rheumatology and therapy (2023)
This study was registered with the Clinical Trial Registry of the University Hospital Medical Information Network (Japan) as UMIN000049243.